Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Wilms Tumor 1Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Thyroid Cancer, Papillary 1Precancerous Conditions 1Lymphatic Metastasis 1Lung Neoplasms 1Kidney Neoplasms 1Gliosarcoma 1Glioblastoma 1Cervical Neoplasia 1Breast Neoplasms 1Brain Neoplasms 1

Interventions

aldesleukin 26Sunitinib 25Interferon-alpha 21Everolimus 18Sorafenib 16Cyclophosphamide 16Filgrastim 13Bevacizumab 13Nivolumab 11Gemcitabine 11Interleukin-2 10Axitinib 10fludarabine phosphate 9Gene Expression Profiling 9temsirolimus 8Peripheral Blood Stem Cell Transplantation 8Doxorubicin 8pembrolizumab 7Radiotherapy 6Radiosurgery 6Polymerase Chain Reaction 6Ipilimumab 6Carboplatin 6sargramostim 5Ifosfamide 5Fluorouracil 5Erlotinib Hydrochloride 5Capecitabine 5Bortezomib 5atezolizumab 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Kidney Neoplasms × Spectrum Analysis × Clear all
NCT01542333 2016-05-18

Studying Biomarkers in Samples From Younger Patients With Wilms Tumor

Children's Oncology Group

Completed
20 enrolled
Genitourinary

Kidney Neoplasms, Wilms Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡